256 related articles for article (PubMed ID: 36156927)
21. miR-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy
Sun C; Wang FJ; Zhang HG; Xu XZ; Jia RC; Yao L; Qiao PF
World J Gastroenterol; 2017 Mar; 23(10):1816-1827. PubMed ID: 28348487
[TBL] [Abstract][Full Text] [Related]
22. microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor.
Xu CB; Liu XS; Li JQ; Zhao X; Xin D; Yu D
J Cell Biochem; 2019 Jun; 120(6):10830-10846. PubMed ID: 30706537
[TBL] [Abstract][Full Text] [Related]
23. TGF-β: an emerging player in drug resistance.
Brunen D; Willems SM; Kellner U; Midgley R; Simon I; Bernards R
Cell Cycle; 2013 Sep; 12(18):2960-8. PubMed ID: 23974105
[TBL] [Abstract][Full Text] [Related]
24. TGFβ1-induced cell motility but not cell proliferation is mediated through Cten in colorectal cancer.
Asiri A; Raposo TP; Alfahed A; Ilyas M
Int J Exp Pathol; 2018 Dec; 99(6):323-330. PubMed ID: 30648319
[TBL] [Abstract][Full Text] [Related]
25. Role of the transforming growth factor-β signaling pathway in the pathogenesis of colorectal cancer.
Soleimani A; Pashirzad M; Avan A; Ferns GA; Khazaei M; Hassanian SM
J Cell Biochem; 2019 Jun; 120(6):8899-8907. PubMed ID: 30556274
[TBL] [Abstract][Full Text] [Related]
26. Fucosylated TGF-β receptors transduces a signal for epithelial-mesenchymal transition in colorectal cancer cells.
Hirakawa M; Takimoto R; Tamura F; Yoshida M; Ono M; Murase K; Sato Y; Osuga T; Sato T; Iyama S; Miyanishi K; Takada K; Hayashi T; Kobune M; Kato J
Br J Cancer; 2014 Jan; 110(1):156-63. PubMed ID: 24253505
[TBL] [Abstract][Full Text] [Related]
27. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
[TBL] [Abstract][Full Text] [Related]
28. Ski prevents TGF-β-induced EMT and cell invasion by repressing SMAD-dependent signaling in non-small cell lung cancer.
Yang H; Zhan L; Yang T; Wang L; Li C; Zhao J; Lei Z; Li X; Zhang HT
Oncol Rep; 2015 Jul; 34(1):87-94. PubMed ID: 25955797
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of transforming growth factor beta (TGF-β) signaling axis molecules and E-cadherin in colorectal cancer.
Lampropoulos P; Zizi-Sermpetzoglou A; Rizos S; Kostakis A; Nikiteas N; Papavassiliou AG
Tumour Biol; 2012 Aug; 33(4):1005-14. PubMed ID: 22278155
[TBL] [Abstract][Full Text] [Related]
30. Pien Tze Huang inhibits liver metastasis by targeting TGF-β signaling in an orthotopic model of colorectal cancer.
Lin W; Zhuang Q; Zheng L; Cao Z; Shen A; Li Q; Fu C; Feng J; Peng J
Oncol Rep; 2015 Apr; 33(4):1922-8. PubMed ID: 25653118
[TBL] [Abstract][Full Text] [Related]
31. Modified Shenlingbaizhu Decoction represses the pluripotency of colorectal cancer stem cells by inhibiting TGF-β mediated EMT program.
Dai Y; Wang H; Sun R; Diao J; Ma Y; Shao M; Xu Y; Zhang Q; Gao Z; Zeng Z; Zhang L; Sun X
Phytomedicine; 2022 Aug; 103():154234. PubMed ID: 35689903
[TBL] [Abstract][Full Text] [Related]
32. Difference of TGF-β/Smads signaling pathway in epithelial-mesenchymal transition of normal colonic epithelial cells induced by tumor-associated fibroblasts and colon cancer cells.
Wang XL; Huang C
Mol Biol Rep; 2019 Jun; 46(3):2749-2759. PubMed ID: 30835040
[TBL] [Abstract][Full Text] [Related]
33. Extracellular signal-regulated kinase and Akt activation play a critical role in the process of hepatocyte growth factor-induced epithelial-mesenchymal transition.
Tanahashi T; Osada S; Yamada A; Kato J; Yawata K; Mori R; Imai H; Sasaki Y; Saito S; Tanaka Y; Nonaka K; Yoshida K
Int J Oncol; 2013 Feb; 42(2):556-64. PubMed ID: 23229794
[TBL] [Abstract][Full Text] [Related]
34. MEGF6 Promotes the Epithelial-to-Mesenchymal Transition via the TGFβ/SMAD Signaling Pathway in Colorectal Cancer Metastasis.
Hu H; Wang M; Wang H; Liu Z; Guan X; Yang R; Huang R; Tang Q; Zou C; Wang G; Gao X; Wang X
Cell Physiol Biochem; 2018; 46(5):1895-1906. PubMed ID: 29719292
[TBL] [Abstract][Full Text] [Related]
35. DcR3 induces epithelial-mesenchymal transition through activation of the TGF-β3/SMAD signaling pathway in CRC.
Liu YP; Zhu HF; Liu DL; Hu ZY; Li SN; Kan HP; Wang XY; Li ZG
Oncotarget; 2016 Nov; 7(47):77306-77318. PubMed ID: 27764793
[TBL] [Abstract][Full Text] [Related]
36. KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression.
Ali A; Zhang P; Liangfang Y; Wenshe S; Wang H; Lin X; Dai Y; Feng XH; Moses R; Wang D; Li X; Xiao J
Cell Death Dis; 2015 Mar; 6(3):e1681. PubMed ID: 25766320
[TBL] [Abstract][Full Text] [Related]
37. RUNX1 regulates TGF-β induced migration and EMT in colorectal cancer.
Lu C; Yang Z; Yu D; Lin J; Cai W
Pathol Res Pract; 2020 Nov; 216(11):153142. PubMed ID: 32866710
[TBL] [Abstract][Full Text] [Related]
38. Silencing of lncRNA EZR-AS1 inhibits proliferation, invasion, and migration of colorectal cancer cells through blocking transforming growth factor β signaling.
Liu Z; Wang N; Wang F; Zhang S; Ding J
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693738
[TBL] [Abstract][Full Text] [Related]
39. Neuropilin-2 expression promotes TGF-β1-mediated epithelial to mesenchymal transition in colorectal cancer cells.
Grandclement C; Pallandre JR; Valmary Degano S; Viel E; Bouard A; Balland J; Rémy-Martin JP; Simon B; Rouleau A; Boireau W; Klagsbrun M; Ferrand C; Borg C
PLoS One; 2011; 6(7):e20444. PubMed ID: 21747928
[TBL] [Abstract][Full Text] [Related]
40. Let-7a Inhibits Tumor Metastasis by Regulating TGF-β/Smad Signaling in the Colorectal Adenocarcinoma Cell Line LS-174T.
Cao W; Wang Q; Huang C
Anticancer Res; 2021 Aug; 41(8):3801-3808. PubMed ID: 34281839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]